 CAMBRIDGE, Mass., Feb. 10, 2022 GLOBE NEWSWIRE -- Agios Pharmaceuticals, Inc. NASDAQ: AGIO, a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, today announced the company will host a conference call and live webcast on Thursday, Feb. 24, 2022, at 8:00 a.m. ET to report its fourth quarter and year end 2021 financial results and other business highlights. 